Oruka Therapeutics, Inc.
Pharmaceutical company · Menlo Park, California, United States · Nasdaq: ORKA
Oruka Therapeutics, Inc. is a pharmaceutical company headquartered in Menlo Park, California, United States. Its shares trade on Nasdaq under the ticker ORKA. It has reported private securities offerings to the US SEC, most recently $52 million sold in a notice filed in 2015.
Oruka Therapeutics at a glance
What does Oruka Therapeutics do?
Private fundraising reported to the SEC
8 Form D notices; the most recent reported $51.7 million sold (2015).
Frequently asked questions about Oruka Therapeutics
Where is Oruka Therapeutics headquartered?
Oruka Therapeutics, Inc. is headquartered in Menlo Park, California, United States.
What does Oruka Therapeutics do?
Oruka Therapeutics, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Oruka Therapeutics a public company?
Yes. Oruka Therapeutics, Inc. trades on Nasdaq under the ticker ORKA.
Similar companies
- AN2 Therapeutics, Inc.Menlo Park, California, United States
- Dermira, Inc.Menlo Park, California, United States
- Orca BioSystems IncMenlo Park, California, United States
- CohBar, Inc.Menlo Park, California, United States
- Radionetics Oncology, Inc.Menlo Park, California, United States
- Forty Seven, Inc.Menlo Park, California, United States
- Attenua, Inc.Menlo Park, California, United States
- Corium International, Inc.Menlo Park, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-24. Data licences